Filed: 2/17/2026ACC: 0001104659-26-015412
📋 What this filing means
FORESITE CAPITAL MANAGEMENT VI LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $330.84M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$330.84M
Total AUM (reported)
18.54M
Total Shares
Allocation by class
COM$279.21M84.4%
SPONSORED ADS$34.11M10.3%
SHS$11.25M3.4%
CL A$6.27M1.9%
Portfolio Concentration
Top 3$186.61M56.4%
4–10$127.32M38.5%
11–25$16.91M5.1%
Top 3 weight
56.4%
Top 10 weight
94.9%
Voting Authority Distribution
Total shares with voting rights: 18.54M
Sole
Full voting authority
18.54M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
CG Oncology, Inc.
SOLEShares2.22M
TypeSH
Market value$92.24M
27.88%
Sole
2.22M
Shared
0.00
None
0.00
RAPT Therapeutics, Inc.
SOLEShares1.56M
TypeSH
Market value$52.92M
16.00%
Sole
1.56M
Shared
0.00
None
0.00
ALUMIS INC.
SOLEShares4.25M
TypeSH
Market value$41.46M
12.53%
Sole
4.25M
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares1.36M
TypeSH
Market value$34.11M
10.31%
Sole
1.36M
Shared
0.00
None
0.00
Verastem, Inc.
SOLEShares3.14M
TypeSH
Market value$24.20M
7.32%
Sole
3.14M
Shared
0.00
None
0.00
Denali Therapeutics Inc.
SOLEShares1M
TypeSH
Market value$16.51M
4.99%
Sole
1M
Shared
0.00
None
0.00
Natera, Inc.
SOLEShares67.36K
TypeSH
Market value$15.43M
4.66%
Sole
67.36K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS, INC.
SOLEShares530K
TypeSH
Market value$14.43M
4.36%
Sole
530K
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares146.33K
TypeSH
Market value$11.39M
3.44%
Sole
146.33K
Shared
0.00
None
0.00
Atai Beckley N.V.
SOLEShares2.75M
TypeSH
Market value$11.25M
3.40%
Sole
2.75M
Shared
0.00
None
0.00
Corvus Pharmaceuticals, Inc.
SOLEShares1.38M
TypeSH
Market value$10.64M
3.21%
Sole
1.38M
Shared
0.00
None
0.00
Hinge Health, Inc.
SOLEShares135K
TypeSH
Market value$6.27M
1.90%
Sole
135K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG Oncology, Inc.SOLE | COM | 2.22M | SH | $92.24M 27.88% | 2.22M | 0.00 | 0.00 |
RAPT Therapeutics, Inc.SOLE | COM | 1.56M | SH | $52.92M 16.00% | 1.56M | 0.00 | 0.00 |
ALUMIS INC.SOLE | COM | 4.25M | SH | $41.46M 12.53% | 4.25M | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | SPONSORED ADS | 1.36M | SH | $34.11M 10.31% | 1.36M | 0.00 | 0.00 |
Verastem, Inc.SOLE | COM | 3.14M | SH | $24.20M 7.32% | 3.14M | 0.00 | 0.00 |
Denali Therapeutics Inc.SOLE | COM | 1M | SH | $16.51M 4.99% | 1M | 0.00 | 0.00 |
Natera, Inc.SOLE | COM | 67.36K | SH | $15.43M 4.66% | 67.36K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS, INC.SOLE | COM | 530K | SH | $14.43M 4.36% | 530K | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | COM | 146.33K | SH | $11.39M 3.44% | 146.33K | 0.00 | 0.00 |
Atai Beckley N.V.SOLE | SHS | 2.75M | SH | $11.25M 3.40% | 2.75M | 0.00 | 0.00 |
Corvus Pharmaceuticals, Inc.SOLE | COM | 1.38M | SH | $10.64M 3.21% | 1.38M | 0.00 | 0.00 |
Hinge Health, Inc.SOLE | CL A | 135K | SH | $6.27M 1.90% | 135K | 0.00 | 0.00 |